A Study of Thalidomide in the Treatment of Refractory Uremic Pruritus
Clinical trial NCT05525234 · UNKNOWN
Trial details
- NCT number
- NCT05525234
- Sponsor
- RenJi Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-15
- Primary completion
- 2022-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.